Retatrutide Dosing: What We Know So Far About How Its Used Discover the latest clinical trial insights on retatrutide, a weight loss treatment in development for obesity and type 2 diabetes, including what is currently known about dosing
MOTS-c 2-3x weekly (intermittent) or low-dose daily
Conclusion In conclusion, CVOTs have played a pivotal role in evaluating the cardiovascular safety and efficacy of GLP-1 receptor agonists in patients with T2D
Related Reading What Determines If You Are A Morning Person Or A Night Owl Can You Avoid Diabetes If It Runs In Your Family Lifemd Ozempic Eden Ozempic Pricing and availability current as of June 2026
This distinction is important: insulin is traditionally measured in international units (IU), whereas peptide-based receptor agonists like retatrutide, semaglutide, and tirzepatide are dosed by weight (milligrams)
The bottom line GLP-1 drugs cause muscle loss, but not uniquely the ratio is similar to dieting or surgery